Skip to main content
. Author manuscript; available in PMC: 2011 Apr 1.
Published in final edited form as: Drug Discov Today. 2010 Jan 22;15(7-8):265–271. doi: 10.1016/j.drudis.2010.01.001

Table 1. Protective drugs identified by zebrafish lateral line screen of NINDS Custom Collection II for protection against neomycin-induced hair cell deatha.

Protective drug Known activity
Amsacrine Topoisomerase 2 poison; used as chemotherapeutic agent. Used clinically in other countries; not yet FDA approved.
Carvedilol Beta-2 adrenergic blocker; used for treatment of hypertension and heart failure; FDA approved.
Cepharanthine Plasma membrane stabilizer; used for the treatment of nasal allergy, snake venom hemolysis; possible chemotherapeutic adjunct. Used clinically in other countries; not yet FDA approved.
Drofenine Acetylcholinesterase inhibitor; used as antispasmodic. Used clinically in other countries; not yet FDA approved.
Hexamethyleneamiloride Diuretic, Na/H exchange inhibitor. Derivative of amiloride; FDA approved. Diuretic.
Phenoxybenzamine Alpha-1 adrenergic blocker; used as antihypertensive. FDA approved.
9-amino-1,2,3,4-.tetrahydroacridine (Tacrine) Anticholinergic; acetylcholinesterase inhibitor, used for treatment of Alzheimer's dementia. FDA approved.
a

Modified, with permission from the Association for Research in Otolaryngology, from Ref. [40].